Citations as recorded by:

1. MicroRNA-146a contributes to CD4 T lymphocyte differentiation in patients with thyroid ophthalmopathy

Am J Transl Res, 2017, 9 p. 1801

Citations as recorded by: PMC

2. Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer

Genes Cancer, 2017, 8 p. 566

DOI: 10.18632/genesandcancer.144

Citations as recorded by: PMC

3. SPARC overexpression alters microRNA expression profiles involved in tumor progression

Genes Cancer, 2017, 8 p. 453

DOI: 10.18632/genesandcancer.130

Citations as recorded by: PMC

4. MicroRNAs in Gynecological Cancers: Small molecules with big implications

Cancer Lett, 2017, 407 p. 123

DOI: 10.1016/j.canlet.2017.05.011

Citations as recorded by: Cross Ref PMC

5. Entangling Relation of Micro RNA-let7, miRNA-200 and miRNA-125 with Various Cancers

Pathol. Oncol. Res., 2017, 23(4) p. 707

DOI: 10.1007/s12253-016-0184-0

Citations as recorded by: Cross Ref

6. Lower Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Promotes the Proliferation and Migration of Endometrial Carcinoma

Med Sci Monit, 2017, 23 p. 966

DOI: 10.12659/MSM.899341

Citations as recorded by: Cross Ref PMC

7. MicroRNA-125b targeted STAT3 to inhibit laryngeal squamous cell carcinoma cell growth and motility

Oncol Lett, 2017, 14 p. 480

DOI: 10.3892/ol.2017.6155

Citations as recorded by: PMC

8. Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients

Oncol Lett, 2017, 13 p. 867

DOI: 10.3892/ol.2016.5482

Citations as recorded by: PMC

9. Dysfunction of microRNA-32 regulates ubiquitin ligase FBXW7 in multiple myeloma disease

Onco Targets Ther, 2016, 9 p. 6573

DOI: 10.2147/OTT.S105945

Citations as recorded by: PMC

10. Involvement of microRNAs in HER2 signaling and trastuzumab treatment

Tumor Biol., 2016, 37(12) p. 15437

DOI: 10.1007/s13277-016-5405-3

Citations as recorded by: Cross Ref

11. The roles of microRNAs related with progression and metastasis in human cancers

Tumor Biol., 2016, 37(12) p. 15383

DOI: 10.1007/s13277-016-5436-9

Citations as recorded by: Cross Ref

12. The future therapy of endometrial cancer: microRNA’s functionality, capability, and putative clinical application

Arch Gynecol Obstet, 2016, 294(5) p. 889

DOI: 10.1007/s00404-016-4194-7

Citations as recorded by: Cross Ref

13. miR-128 regulates the apoptosis and proliferation of glioma cells by targeting RhoE

Oncol Lett, 2016, 11 p. 904

DOI: 10.3892/ol.2015.3927

Citations as recorded by: Cross Ref PMC

14. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma

Int J Clin Exp Pathol, 2015, 8 p. 10800

Citations as recorded by: PMC

15. The expression of miR-125b regulates angiogenesis during the recovery of heat-denatured HUVECs

Burns, 2015, 41(4) p. 803

DOI: 10.1016/j.burns.2014.10.012

Citations as recorded by: Cross Ref

16. The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review

Arch Gynecol Obstet, 2015, 292(2) p. 271

DOI: 10.1007/s00404-015-3660-y

Citations as recorded by: Cross Ref

17. Up-Regulation of miR-9 Target CBX7 to Regulate Invasion Ability of Bladder Transitional Cell Carcinoma

Med Sci Monit, 2015, 21 p. 225

DOI: 10.12659/MSM.893232

Citations as recorded by: Cross Ref PMC

18. Expression and Clinical Significance of microRNA-1246 in Human Oral Squamous Cell Carcinoma

Med Sci Monit, 2015, 21 p. 776

DOI: 10.12659/MSM.892508

Citations as recorded by: Cross Ref PMC

19. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma

Med Sci Monit, 2015, 21 p. 1864

DOI: 10.12659/MSM.893082

Citations as recorded by: Cross Ref PMC

20. Inhibition of MiR-199a-5p Reduced Cell Proliferation in Autosomal Dominant Polycystic Kidney Disease through Targeting CDKN1C

Med Sci Monit, 2015, 21 p. 195

DOI: 10.12659/MSM.892141

Citations as recorded by: Cross Ref PMC

21. MicroRNAS in endometrial cancer: recent advances and potential clinical applications

EXCLI J, 2015, 14 p. 190

DOI: 10.17179/excli2014-590

Citations as recorded by: PMC

22. Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies

Clin. Sci., 2015, 128(3) p. 153

DOI: 10.1042/CS20140087

Citations as recorded by: Cross Ref

23. MiR-320a down-regulation mediates bladder carcinoma invasion by targeting ITGB3

Mol Biol Rep, 2014, 41(4) p. 2521

DOI: 10.1007/s11033-014-3110-0

Citations as recorded by: Cross Ref

24. HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology

Clinical Investigation, 2014, 4(8) p. 705

DOI: 10.4155/cli.14.62

Citations as recorded by: Cross Ref

25. miR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3

Mol Cell Biochem, 2014, 388(1-2) p. 219

DOI: 10.1007/s11010-013-1913-2

Citations as recorded by: Cross Ref

26. Effect of mTOR Inhibitors in Nude Mice with Endometrial Carcinoma and Variable PTEN Expression Status

Med Sci Monit Basic Res, 2014, 20 p. 146

DOI: 10.12659/MSMBR.892514

Citations as recorded by: Cross Ref PMC

27. Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves’ ophthalmopathy

Med Sci Monit, 2014, 20 p. 639

DOI: 10.12659/MSM.890686

Citations as recorded by: Cross Ref PMC

28. Circulating miR-221 Expression Level and Prognosis of Cutaneous Malignant Melanoma

Med Sci Monit, 2014, 20 p. 2472

DOI: 10.12659/MSM.891327

Citations as recorded by: Cross Ref PMC

29. MiR-32 Functions as a Tumor Suppressor and Directly Targets EZH2 in Human Oral Squamous Cell Carcinoma

Med Sci Monit, 2014, 20 p. 2527

DOI: 10.12659/MSM.892636

Citations as recorded by: Cross Ref PMC

30. MiR-210 Up-Regulation Inhibits Proliferation and Induces Apoptosis in Glioma Cells by Targeting SIN3A

Med Sci Monit, 2014, 20 p. 2571

DOI: 10.12659/MSM.892994

Citations as recorded by: Cross Ref PMC

31. MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies

Clinical Colorectal Cancer, 2014, 13(1) p. 37

DOI: 10.1016/j.clcc.2013.11.006

Citations as recorded by: Cross Ref

32. Good guy or bad guy: the opposing roles of microRNA 125b in cancer

Cell Commun Signal, 2014, 12 p. 30

DOI: 10.1186/1478-811X-12-30

Citations as recorded by: PMC

33. Diverse functions of miR-125 family in different cell contexts

J Hematol Oncol, 2013, 6(1) p. 6

DOI: 10.1186/1756-8722-6-6

Citations as recorded by: Cross Ref PMC

34. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1

587(23) p. 3875

DOI: 10.1016/j.febslet.2013.10.023

Citations as recorded by: Cross Ref

35. MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas

J Oral Maxillofac Res, 2013, 4

DOI: 10.5037/jomr.2013.4102

Citations as recorded by: PMC

36. Experimental study on the facilitative effects of miR-125b on the differentiation of rat bone marrow mesenchymal stem cells into neuron-like cells

Cell Biol Int, 2013, 37(8) p. 812

DOI: 10.1002/cbin.10103

Citations as recorded by: Cross Ref

37. MicroRNAs in endometrial cancer

Int J Clin Oncol, 2013, 18(2) p. 186

DOI: 10.1007/s10147-013-0526-9

Citations as recorded by: Cross Ref